• 1. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 2. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

Introduction to 2,6-Dimethoxypyrimidine-4-carboxylic Acid methyl ester (CAS No: 55878-45-0)

2,6-Dimethoxypyrimidine-4-carboxylic Acid methyl ester, identified by its Chemical Abstracts Service (CAS) number 55878-45-0, is a significant compound in the realm of organic chemistry and pharmaceutical research. This heterocyclic aromatic ester possesses a pyrimidine core, which is a crucial structural motif in many biologically active molecules. The presence of methoxy and ester functional groups further enhances its utility in synthetic chemistry and drug development.

The compound’s molecular structure, characterized by a pyrimidine ring substituted at the 2- and 6-positions with methoxy groups and an ester group at the 4-position, makes it a versatile intermediate in the synthesis of more complex molecules. Pyrimidine derivatives are well-documented for their roles in various biological processes, including DNA and RNA synthesis, making this compound of particular interest to researchers in medicinal chemistry.

In recent years, there has been a surge in research focused on developing novel pyrimidine-based therapeutics. The unique electronic properties of the pyrimidine ring, combined with the electron-donating effects of the methoxy groups, make 2,6-Dimethoxypyrimidine-4-carboxylic Acid methyl ester an excellent candidate for further functionalization. This has led to its incorporation into various synthetic pathways aimed at creating new pharmacophores with potential applications in treating a range of diseases.

One of the most compelling aspects of this compound is its role as a building block in the synthesis of nucleoside analogs. Nucleoside analogs are synthetic molecules that mimic the structure of natural nucleosides but have modified sugar or base components. These modifications can lead to enhanced stability, improved bioavailability, or altered biological activity. The ester group in 2,6-Dimethoxypyrimidine-4-carboxylic Acid methyl ester provides a convenient handle for further chemical modifications, allowing researchers to tailor the molecule for specific biological targets.

Recent studies have highlighted the potential of pyrimidine derivatives as inhibitors of enzymes involved in cancer metabolism. For instance, certain pyrimidine-based compounds have shown promise in inhibiting kinases and other enzymes that are overexpressed in tumor cells. The methoxy groups in this compound may play a role in modulating the enzyme’s active site, thereby enhancing binding affinity and therapeutic efficacy. This has spurred interest in exploring derivatives of 2,6-Dimethoxypyrimidine-4-carboxylic Acid methyl ester as potential anticancer agents.

The pharmaceutical industry has also been keen on exploring this compound for its antimicrobial properties. Pyrimidine derivatives have long been recognized for their ability to disrupt bacterial DNA replication and transcription processes. The structural features of 2,6-Dimethoxypyrimidine-4-carboxylic Acid methyl ester, particularly the electron-rich pyrimidine ring and the ester functionality, make it a promising candidate for developing novel antibiotics or antifungal agents. Researchers are currently investigating its efficacy against resistant strains of bacteria and fungi.

In addition to its applications in drug development, 2,6-Dimethoxypyrimidine-4-carboxylic Acid methyl ester finds utility in materials science and agrochemical research. Its ability to undergo various chemical transformations makes it a valuable intermediate for synthesizing polymers with unique properties. These polymers can be used in coatings, adhesives, and other industrial applications where specific chemical characteristics are required.

The agrochemical sector has also shown interest in this compound due to its potential as a precursor for herbicides and pesticides. Pyrimidine-based compounds have been widely used in agriculture due to their effectiveness in controlling pests and weeds. By modifying the structure of 2,6-Dimethoxypyrimidine-4-carboxylic Acid methyl ester, researchers aim to develop new agrochemicals that are more environmentally friendly while maintaining high efficacy.

The synthesis of 2,6-Dimethoxypyrimidine-4-carboxylic Acid methyl ester typically involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include condensation reactions between appropriate precursors followed by functional group transformations such as methylation and esterification. Advances in catalytic methods have significantly improved the efficiency of these synthetic pathways, making it more feasible to produce large quantities of the compound for research and industrial purposes.

The safety profile of this compound is another critical consideration for researchers and manufacturers alike. While it is not classified as hazardous under standard conditions, proper handling procedures must be followed to minimize exposure risks. Standard laboratory practices such as wearing appropriate personal protective equipment (PPE) and working under controlled conditions are essential when handling any chemical substance.

In conclusion, 2,6-Dimethoxypyrimidine-4-carboxylic Acid methyl ester (CAS No: 55878-45-0) is a multifaceted compound with significant applications across multiple scientific disciplines. Its role as an intermediate in pharmaceutical synthesis underscores its importance in drug discovery efforts aimed at treating various diseases. Additionally, its utility in materials science and agrochemical research highlights its versatility beyond traditional medicinal chemistry applications.

• 59864-30-1(2,4-Dimethoxypyrimidine-6-carboxylic Acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)